Company
Arc-1
Arc-1 publishes compounded tirzepatide and compounded semaglutide, from $149 to $199.99 a month.
- 2 programs
- 2 molecules
- 2 readings
Read from arc-1.co on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.
Go to Arc-1
We earn nothing from this link. Arc-1 has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
What it costs
first month, including the required fees on record · Product page starting price
first month, including the required fees on record · Collection page listing
Terms
Not yet checked: pharmacy, membership, consultation fee and states.
Terms can differ between this company’s programs; each entry carries its own.
Programs
Notes
Recorded against this company rather than one program.
September 2, 2026
- 1. Two contradictions worth flagging: (1) the homepage collection grid prices tirzepatide the same as semaglutide ('From $199.99'), but the tirzepatide product detail page itself advertises 'Starting at $149/month' -- the two on-site prices for the same product disagree. (2) The state-exclusion list differs by product page: semaglutide excludes 'Arkansas, Indiana, Minnesota, Puerto Rico, or South Carolina' while tirzepatide excludes 'California, Arkansas, Indiana, Minnesota, or South Carolina' (California in one list, Puerto Rico in the other, not both). (3) Every dose variant on both product pages is marked 'Variant sold out or unavailable' at the moment fetched, so the advertised prices may not currently resolve to a purchasable product. Only a 30-day return policy on delivered goods was found; no subscription-cancellation policy was found.
Before you act
Cite this
Treatment Registry. (2026). Arc-1: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/arc-1